Meglasson; Martin D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meglasson; Martin D..The latest application filed is for "cannula for minimizing dilution of dosing during nitric oxide delivery".

Company Profile

3.13.13

Meglasson; Martin D. - Bloomsbury NJ
Meglasson, Martin D. - Kalamazoo MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20210260327 - Flanagan; Craig ; et al.	2021-08-26
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 10,918,819 - Flanagan , et al. February 16, 2	2021-02-16
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20200171259 - Flanagan; Craig ; et al.	2020-06-04
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 10,556,082 - Flanagan , et al. Feb	2020-02-11
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 10,130,783 - Flanagan , et al. November 20, 2	2018-11-20
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20180104432 - Flanagan; Craig ; et al.	2018-04-19
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 9,795,756 - Flanagan , et al. October 24, 2	2017-10-24
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20170128690 - Flanagan; Craig ; et al.	2017-05-11
Labeled alginate conjugates for molecular imaging applications Grant 9,562,113 - Ruan , et al. February 7, 2	2017-02-07
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 9,550,039 - Flanagan , et al. January 24, 2	2017-01-24
Labeled Alginate Conjugates For Molecular Imaging Applications App 20160115252 - Ruan; Fuqiang ; et al.	2016-04-28
Labeled alginate conjugates for molecular imaging applications Grant 9,260,399 - Ruan , et al. February 16, 2	2016-02-16
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20150238720 - Flanagan; Craig ; et al.	2015-08-27
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 9,032,959 - Flanagan , et al. May 19, 2	2015-05-19
Labeled Alginate Conjugates For Molecular Imaging Applications App 20150133645 - Ruan; Fuqiang ; et al.	2015-05-14
Labeled alginate conjugates for molecular imaging applications Grant 8,974,766 - Ruan , et al. March 10, 2	2015-03-10
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20140299129 - Flanagan; Craig ; et al.	2014-10-09
Cannula for minimizing dilution of dosing during nitric oxide delivery Grant 8,770,199 - Flanagan , et al. July 8, 2	2014-07-08
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20140166009 - Flanagan; Craig ; et al.	2014-06-19
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20140158121 - Flanagan; Craig ; et al.	2014-06-12
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery App 20140150789 - Flanagan; Craig ; et al.	2014-06-05
Labeled Alginate Conjugates for Molecular Imaging Applications App 20130149242 - Ruan; Fuqiang ; et al.	2013-06-13
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus App 20020082448 - Larsen, Scott D. ; et al.	2002-06-27
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus Grant 5,994,577 - Larsen , et al. November 30, 1	1999-11-30
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus Grant 5,955,617 - Larsen , et al. September 21, 1	1999-09-21
Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (NIDDM) Grant 5,132,324 - Meglasson July 21, 1	1992-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.